Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
INSIGHT PROVIDER
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
Message
Follow
Location:
China
Joined:
02 October 2020
971
Insights
330.1k
Views
437
Followers
China
•
Health Care
•
Equity Bottom-Up
•
Thematic (Sector/Industry)
Message
Follow
Regions
Sectors
Verticals
More Filters
Refresh
Top Picks Only
Recent
bullish
•
China Resources Beverage
•
21 May 2024 08:55
Pre-IPO China Resources Beverage - Here Are the Concerns and the Risks Behind
CR Beverage is growing steadily but the momentum/profitability far inferior to peers. Growth rate of packaged water business is lower than the...
Xinyao (Criss) Wang
175 Views
Share
bullish
•
Giant Biogene
•
20 May 2024 08:55
Giant Biogene (2367.HK) Placement - A Turning Point in Performance Growth Has Emerged
Giant Biogene's growth is slowing down with uncertain long-term outlook.Selling Class III medical devices faces challenge in marketing.Reasonable...
Xinyao (Criss) Wang
226 Views
Share
bearish
•
WuXi AppTec
•
19 May 2024 16:10
China Healthcare Weekly (May.19)- Decoupling Deadline with WuXi,Biotech Classification,Deals Cooling
Investment/financing deals cooling in 24Q1. It's better not to spend too much time on Biotech that located in China and only for China...
Xinyao (Criss) Wang
247 Views
Share
bullish
•
L'Occitane
•
17 May 2024 12:23
L'Occitane (973.HK) Privatization - The Offer Price Is Good Enough
The Offeror has received valid expressions of interest from Minority Shareholders holding, in aggregate, not less than 10% of Disinterested Shares....
Xinyao (Criss) Wang
734 Views
Share
bearish
•
WuXi AppTec
•
16 May 2024 09:16
WuXi AppTec (2359.HK/603259.CH) - The Pain of 2024 Has Just Begun
House Committee advances Bill to restrict WuXi AppTec/WuXi Bio, which then needs to be passed by a full vote in House/Senate and finally signed...
Xinyao (Criss) Wang
483 Views
Share
1
2
3
4
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.32.0
x